We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blocking the Thromboxane Receptor Prevents Alzheimer's Disease in Mouse Model

By LabMedica International staff writers
Posted on 30 Nov 2014
Print article
A recent study carried out on a transgenic mouse model of Alzheimer's disease identified the thromboxane receptor (TP) as an active contributor to the development of the disease and a feasible target for drugs to treat it.

Investigators at Temple University (Philadelphia, PA, USA) had reported previously that 8-isoprostaneF2alpha (8ISO)—a marker for lipid oxidation and an indicator of oxidative stress—increased brain amyloid-beta levels and deposition in the Tg2576 mouse Alzheimer's disease model.

In the current study, the investigators continued this line of research by examining how (8ISO) affected behavior and tau protein metabolism. To this end, they characterized the behavioral, biochemical, and neuropathologic effects of 8ISO in the triple transgenic mouse model.

They reported in the October 10, 2014, online edition of the journal Neurobiology of Aging that compared with controls, the transgenic mice receiving 8ISO showed significant memory deficits, increase in tau phosphorylation, activation of the cyclin kinase-5 pathway, and neuroinflammation. All these effects could be prevented by treatment with drugs that blocked the thromboxane receptor, a G-protein coupled receptor coupled to the G protein Gq.

“Besides the two major signature brain pathologies associated with Alzheimer’s disease, amyloid beta plaques and the tangles which are formed from the phosphorylation of the tau protein, researchers have also known for a while that there is a signature from oxidation stress,” said senior author Dr. Domenico Praticò, professor of pharmacology, microbiology, and immunology in Temple University. “But it has always been believed that oxidative stress was just a bystander and did not have an active function in the development of the disease.”

“For the first time we have identified this receptor as the culprit responsible for the bad things that happen with the disease when high levels of oxygen free radicals are produced,” said Dr. Praticò. “Basically, it sends the wrong message inside the neuronal cells, and with time, this definitely will result in all the clinical manifestations of the disease, such as cognitive impairment, loss of memory, and brain cell death. This indirectly confirmed for us that the free radicals worked through this receptor.”

Related Links:

Temple University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.